BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9415656)

  • 1. Azathioprine in patients with juvenile chronic arthritis: a longterm followup study.
    Savolainen HA; Kautiainen H; Isomäki H; Aho K; Verronen P
    J Rheumatol; 1997 Dec; 24(12):2444-50. PubMed ID: 9415656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorambucil in severe juvenile chronic arthritis: longterm followup with special reference to amyloidosis.
    Savolainen HA
    J Rheumatol; 1999 Apr; 26(4):898-903. PubMed ID: 10229413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10 year followup.
    Fantini F; Gerloni V; Gattinara M; Cimaz R; Arnoldi C; Lupi E
    J Rheumatol; 2003 Mar; 30(3):579-84. PubMed ID: 12610820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antirheumatic effects of first-line agents in the treatment of juvenile chronic arthritis.
    Ailioaie C; Lupuşoru-Ailioaie LM
    Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):134-8. PubMed ID: 10756785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination drug therapy of seropositive rheumatoid arthritis.
    McCarty DJ; Harman JG; Grassanovich JL; Qian C; Klein JP
    J Rheumatol; 1995 Sep; 22(9):1636-45. PubMed ID: 8523336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study.
    Gerloni V; Pontikaki I; Gattinara M; Desiati F; Lupi E; Lurati A; Salmaso A; Fantini F
    Arthritis Rheum; 2005 Feb; 52(2):548-53. PubMed ID: 15693004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
    Mantzaris GJ; Sfakianakis M; Archavlis E; Petraki K; Christidou A; Karagiannidis A; Triadaphyllou G
    Am J Gastroenterol; 2004 Jun; 99(6):1122-8. PubMed ID: 15180735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged efficacy of etanercept in refractory enthesitis-related arthritis.
    Henrickson M; Reiff A
    J Rheumatol; 2004 Oct; 31(10):2055-61. PubMed ID: 15468375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longterm outcome of amyloidosis associated with juvenile idiopathic arthritis.
    Immonen K; Savolainen A; Kautiainen H; Hakala M
    J Rheumatol; 2008 May; 35(5):907-12. PubMed ID: 18381779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.
    Prince FH; Twilt M; ten Cate R; van Rossum MA; Armbrust W; Hoppenreijs EP; van Santen-Hoeufft M; Koopman-Keemink Y; Wulffraat NM; van Suijlekom-Smit LW
    Ann Rheum Dis; 2009 May; 68(5):635-41. PubMed ID: 18413443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group.
    van Rossum MA; Fiselier TJ; Franssen MJ; Zwinderman AH; ten Cate R; van Suijlekom-Smit LW; van Luijk WH; van Soesbergen RM; Wulffraat NM; Oostveen JC; Kuis W; Dijkstra PF; van Ede CF; Dijkmans BA
    Arthritis Rheum; 1998 May; 41(5):808-16. PubMed ID: 9588731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin therapy in systemic onset juvenile rheumatoid arthritis: a followup study.
    Uziel Y; Laxer RM; Schneider R; Silverman ED
    J Rheumatol; 1996 May; 23(5):910-8. PubMed ID: 8724308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.
    Quartier P; Taupin P; Bourdeaut F; Lemelle I; Pillet P; Bost M; Sibilia J; Koné-Paut I; Gandon-Laloum S; LeBideau M; Bader-Meunier B; Mouy R; Debré M; Landais P; Prieur AM
    Arthritis Rheum; 2003 Apr; 48(4):1093-101. PubMed ID: 12687553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis.
    Reiff A; Rawlings DJ; Shaham B; Franke E; Richardson L; Szer IS; Bernstein BH
    J Rheumatol; 1997 Dec; 24(12):2436-43. PubMed ID: 9415655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone is effective in the treatment of severe growth retardation in children with juvenile chronic arthritis. Double blind placebo-controlled followup study.
    Saha MT; Haapasaari J; Hannula S; Sarna S; Lenko HL
    J Rheumatol; 2004 Jul; 31(7):1413-7. PubMed ID: 15229965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical feature, diagnosis and treatment of uveitis associated with juvenile chronic arthritis].
    Zhang Z; Yang PZ; Zhou HY; Yu Q; Huang XK; Li B
    Zhonghua Yan Ke Za Zhi; 2005 Apr; 41(4):346-9. PubMed ID: 15924698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial.
    Brinkman DM; de Kleer IM; ten Cate R; van Rossum MA; Bekkering WP; Fasth A; van Tol MJ; Kuis W; Wulffraat NM; Vossen JM
    Arthritis Rheum; 2007 Jul; 56(7):2410-21. PubMed ID: 17599770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sandimmun-Neoral--a new quality of life for patients with severe systemic juvenile rheumatoid arthritis].
    Alekseeva EI; Shakhbazian IE
    Ter Arkh; 1999; 71(5):26-9. PubMed ID: 10399226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial.
    Lovell DJ; Giannini EH; Reiff A; Jones OY; Schneider R; Olson JC; Stein LD; Gedalia A; Ilowite NT; Wallace CA; Lange M; Finck BK; Burge DJ;
    Arthritis Rheum; 2003 Jan; 48(1):218-26. PubMed ID: 12528122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.